MA20150144A1 - Kit de diagnostic de la leucemie myeloide chronique en reaction multiplex et ses applications dans le suivi du traitement et de la maladie residuelle - Google Patents

Kit de diagnostic de la leucemie myeloide chronique en reaction multiplex et ses applications dans le suivi du traitement et de la maladie residuelle

Info

Publication number
MA20150144A1
MA20150144A1 MA36330A MA36330A MA20150144A1 MA 20150144 A1 MA20150144 A1 MA 20150144A1 MA 36330 A MA36330 A MA 36330A MA 36330 A MA36330 A MA 36330A MA 20150144 A1 MA20150144 A1 MA 20150144A1
Authority
MA
Morocco
Prior art keywords
kit
diagnosis
monitoring
treatment
residual disease
Prior art date
Application number
MA36330A
Other languages
English (en)
Other versions
MA36330B1 (fr
Inventor
Hassane Sefrioui El
Moumen Abdeladim
Elamrani Manale
Elhadi Hichem
Bouchoutrouch Nadia
Original Assignee
Mascir Morrocan Foundation For Advanced Science Innovation & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mascir Morrocan Foundation For Advanced Science Innovation & Res filed Critical Mascir Morrocan Foundation For Advanced Science Innovation & Res
Priority to MA36330A priority Critical patent/MA36330B1/fr
Priority to PCT/MA2014/000031 priority patent/WO2015060703A2/fr
Publication of MA20150144A1 publication Critical patent/MA20150144A1/fr
Publication of MA36330B1 publication Critical patent/MA36330B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne un kit de diagnostic in vitro pour l'identification et la quantification de la translocation génétique bcr-abl présent dans le cas de leucémie myéloïde chronique (lmc) et la leucémie iymphoblastique aigue (lla). Le présent kit est composée d'une combinaison innovante de nouveaux sets d'amorces et de sondes et d'une série de dilution plasmidique calibrant permettant la détection spécifique et la quantification du gène bcr-abl et du gène de référence abll en utilisant la méthode de pcr en temps réel (qpcr) en format multiplex ou simplex. Le présent kit est destiné pour le diagnostic, le suivi du traitement et l'établissement de la maladie résiduelle dans le cas de la lmcet lla.
MA36330A 2013-10-10 2013-10-10 Kit de diagnostic de la leucemie myeloide chronique en reaction multiplex et ses applications dans le suivi du traitement et de la maladie residuelle MA36330B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MA36330A MA36330B1 (fr) 2013-10-10 2013-10-10 Kit de diagnostic de la leucemie myeloide chronique en reaction multiplex et ses applications dans le suivi du traitement et de la maladie residuelle
PCT/MA2014/000031 WO2015060703A2 (fr) 2013-10-10 2014-11-11 Kit de diagnostic de la leucemie myeloide chronique en reaction multiplex et ses applications dans le suivi du tratement et de la maladie residuelle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA36330A MA36330B1 (fr) 2013-10-10 2013-10-10 Kit de diagnostic de la leucemie myeloide chronique en reaction multiplex et ses applications dans le suivi du traitement et de la maladie residuelle

Publications (2)

Publication Number Publication Date
MA20150144A1 true MA20150144A1 (fr) 2015-05-29
MA36330B1 MA36330B1 (fr) 2016-04-29

Family

ID=52444609

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36330A MA36330B1 (fr) 2013-10-10 2013-10-10 Kit de diagnostic de la leucemie myeloide chronique en reaction multiplex et ses applications dans le suivi du traitement et de la maladie residuelle

Country Status (2)

Country Link
MA (1) MA36330B1 (fr)
WO (1) WO2015060703A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106701957A (zh) * 2017-01-12 2017-05-24 广州蓝吉生物技术有限公司 一种检测融合基因BCR‑ABL(P210）mRNA表达的试剂盒
CN109706147A (zh) * 2018-05-09 2019-05-03 深圳市第二人民医院 环状RNA circBA9.3及其在制备CML诊断试剂盒中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1454994A1 (fr) * 2003-03-07 2004-09-08 Université de la Méditerranée Procédé stamdardisé et optimisé d'amplification en chaine par transcription inversé et amplification quantitative en temps réel pour la détection d'une pathologie résiduelle minime de la leucémie
KR100652247B1 (ko) * 2004-06-29 2006-12-08 가톨릭대학교 산학협력단 Ｂｃｒ-ａｂｌ 정량키트
CN101624621B (zh) * 2008-07-11 2012-01-18 北京大学人民医院 一种定量检测BCR/ABL mRNA水平的试剂盒
CN101701253B (zh) * 2009-11-26 2012-05-30 南方医科大学 一种用于检测基因表达的双重荧光定量pcr试剂盒
WO2013036867A2 (fr) * 2011-09-08 2013-03-14 The Regents Of The University Of California Compositions et procédés destinés à la détection et à l'élimination du cancer et de cellules souches cancéreuses
CN102827937B (zh) * 2012-09-06 2014-03-19 上海源奇生物医药科技有限公司 一种检测白血病相关融合基因的引物和探针、及其试剂盒
MA35216B1 (fr) * 2012-09-13 2014-07-03 Mascir Sondes et amorces pour la detection du gene bcr-abl en reaction duplex

Also Published As

Publication number Publication date
WO2015060703A3 (fr) 2015-08-13
WO2015060703A4 (fr) 2015-10-01
MA36330B1 (fr) 2016-04-29
WO2015060703A2 (fr) 2015-04-30

Similar Documents

Publication Publication Date Title
Papantonis et al. TNFα signals through specialized factories where responsive coding and miRNA genes are transcribed
Lahra et al. A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia
Labade et al. HOXA repression is mediated by nucleoporin Nup93 assisted by its interactors Nup188 and Nup205
Wu et al. Single cell microRNA analysis using microfluidic flow cytometry
AU2014206553B2 (en) miRNA-124 as a biomarker
MX2019005143A (es) Biodetectores para analisis quimico o biologico y metodos para fabricar los mismos.
Ning et al. Characterization of the Merkel cell carcinoma miRNome
WO2019227015A8 (fr) Signatures d'arn circulants spécifiques de la prééclampsie
Ravid et al. Uterine leiomyosarcoma and endometrial stromal sarcoma have unique miRNA signatures
MX2017014859A (es) Metodos y composiciones para diagnosticar o detectar canceres de pulmon.
MY195045A (en) Specific Biomarker Set For Non-Invasive Diagnosis of Liver Cancer
EP3825416A3 (fr) Profils d'expression génique associés au rejet de greffe du rein subclinique
MA36330B1 (fr) Kit de diagnostic de la leucemie myeloide chronique en reaction multiplex et ses applications dans le suivi du traitement et de la maladie residuelle
MA37437A1 (fr) Kit de diagnostic du cancer de sein en réaction qpcr multiplex et son application dans l'évaluation du statut de la protéine her2 et le choix du traitement
EP2895625A1 (fr) Gènes associés à une sensibilité au dasatinib
Tian et al. Expression difference of miR-10b and miR-135b between the fertile and infertile semen samples (p)
CA2978368A1 (fr) Signature de la sante
Batinica et al. Correlation of Merkel cell polyomavirus positivity with PDGFRα mutations and survivin expression in Merkel cell carcinoma
Qin et al. Sonic hedgehog signaling pathway in myelodysplastic syndrome: abnormal activation and jervine intervention
MA35294B1 (fr) Sondes et amorces pour detecter le gene her2 en format multiplexe et ses applications dans le choix du traitement du cancer de sein her2
MA35216B1 (fr) Sondes et amorces pour la detection du gene bcr-abl en reaction duplex
CN102732618A (zh) 用于检测aml1-eto融合基因相对表达量的试剂盒
GB2569932A (en) Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment
EA201792628A2 (ru) Способ специфической идентификации последовательностей днк
CN101580874B (zh) 一种人外周血RORγt转录本荧光定量PCR检测方法